Teicoplanin, an antibiotic medicine, may be a potential option for treating coronavirus disease (Covid-19) patients, according to a research conducted by scientists at Kusuma School of Biological Sciences (KSBS) in Indian Institute of Technology (IIT)-Delhi.
In laboratory experiments, the medicine effectively inhibited the activity of the 3CLpro enzyme that is needed for replication of the Sars-CoV-2 virus, which causes Covid-19.
The medicine was found to be up to 20 times more effective in inhibiting the activity of 3CLpro than some of the medicines that have been used in Covid-19 patients such as anti-malarial drug Hydroxychloroquine (HCQ) and Chloroquine, antibiotic Azithromycin, and anti-Human Immunodeficiency Virus (HIV) medicine Lopinavir.
Also Read: Covid-19: India’s tests per million population cross 50k-mark
“Covid-19 has affected millions of people across the world and there is no specific treatment for the viral infection. We have been working for the last seven to